Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Worth US$ 14,972.6 Million at 9.5% CAGR Forecast by 2026

The Global Acute Bacterial Skin And Skin Structure Infections(ABSSSI) Treatment Market is likely to expand at an impressive 9.5% CAGR between 2019 and 2026, finds Fortune Business Insights in a report, titled “Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment: Global Market Analysis, Insights and Forecast, 2019-2026.”

Recent developments, leading to the launch of novel drugs and therapies associated with the treatment of this disease will give impetus to the market. According to the report, the market was valued at US$ 7,270.9 Mn in 2018. Fortune Business Insights has predicted that the market to reach US$ 14,972.6 Mn by the end of 2026.

The acute bacterial skin and skin structure infections (ABSSSI) are associated with bacterial infections as well as disorders related to skin tissues. The severity of acute bacterial skin and skin structure infections (ABSSSI) has led to an increasing emphasis on the research and development of various drugs and therapeutic procedures associated with the treatment of these diseases.

The complications in differentiating the desirable and negative bacteria have presented several challenges for drug manufacturers. Resulting from this, companies are putting in increased efforts to manufacture efficient drugs and related products for treating acute bacterial skin and skin structure infections (ABSSSI). Additionally, the amount of capital invested in the R&D of these drugs has increased steadily, which in turn has aided the growth of the global acute bacterial skin and skin structure infections (ABSSSI) treatment market in recent years.

Rising Incidence of Hospital-acquired ABSSSI to Boost the Market Size

Among all types, the hospital-acquired infections are likely to witness high growth in the coming years. Hospital acquired infections are one of the leading causes of global deaths.  Fortune Business Insights predicts that the hospital-acquired infections segment will increase with a relatively high CAGR during the forecast period. The methicillin-resistant staphylococcus aureus (MRSA) has accounted for the majority of the hospital-acquired infections around the world.

Furthermore, Fortune Business Insights states that the community-acquired acute bacterial skin and skin structure infections have accounted for a significant market share in 2018. The report provides segmentation of the global market based on several aspects such as infection type, route of administration, distribution channel, and regional demographics. Fortune Business Insights profiles leading segments in the market and provide a detailed analysis of several factors that contribute to the growth of this segment.

North America to Hold Highest Market Share

The growing focus on extensive research activities, especially by leading companies have contributed to the growth of the acute bacterial skin and skin structure infections treatment market in North America. The increasing emphasis on R&D of anti-MRSA drugs in North America, aimed at the treatment of acute bacterial skin and skin structure infections (ABSSSI) have aided the growth of the regional market.

Fortune Business Insights has predicted that the acute bacterial skin and skin structure infections (ABSSSI) treatment market in North America will benefit from a host of ongoing pipeline drugs associated with the treatment of this disease. Having said that, the Asia Pacific is likely to witness a relatively high CAGR during the forecast period.

Fortune Business Insights has profiled some of the leading companies that have made significant contributions to the increase in global acute bacterial skin and skin structure infections (ABSSSI) treatment market value. Some of the prominent companies that are operating in the market are Merck & Co., Inc., Pfizer Inc., MELINTA THERAPEUTICS, INC., ALLERGAN, Paratek Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.

Browse Complete Report Details at

https://www.fortunebusinessinsights.com/industry-reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market-100971

The global acute bacterial skin and skin structure infections (ABSSSI) treatment market is segmented based on: